I4V-MC-JAIA(a): A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients with Systemic Lupus Erythematosus

Project: Research project

Project Details

Description

I4V-MC-JAIA(a): A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients with Systemic Lupus Erythematosus
StatusActive
Effective start/end date5/1/195/31/24

Funding

  • Eli Lilly and Company

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.